In data quality context, why are surrogate endpoints and outdated data problematic?

In data quality context, why are surrogate endpoints and outdated data problematic?

• A. Surrogate endpoints and outdated data are always reliable.
• B. Surrogate endpoints are preferred and outdated data are better.
• C. Reliance on surrogate endpoints or outdated data can misrepresent true outcomes.
• D. All data used are equally valid.

Answer: (C)

In data quality, using surrogate endpoints and outdated data is risky because both can distort what actually happens. A surrogate endpoint is an indirect measure used as a stand-in for a real, meaningful outcome—things like using a lab value or a biomarker to predict ultimate clinical results. These surrogates can be easier to collect, but the connection to the real outcomes patients care about (such as survival, symptom relief, or true cost impact) is not perfect. If the surrogate doesn’t track the true outcome well, decisions based on it can exaggerate or miss the real benefit or harm. Outdated data add another layer of trouble. Data from the past may not reflect current practice, patient populations, costs, or technologies. Treatments evolve, prices change, and patient characteristics shift; using old data can lead to incorrect conclusions about effectiveness, safety, or value in today’s context. Together, reliance on surrogate endpoints or outdated data can misrepresent true outcomes, which is why they’re considered problematic for accurate data interpretation. By contrast, focusing on direct, clinically meaningful endpoints and current, relevant data helps ensure conclusions reflect what actually matters to patients and to practice today.

In data quality, using surrogate endpoints and outdated data is risky because both can distort what actually happens. A surrogate endpoint is an indirect measure used as a stand-in for a real, meaningful outcome—things like using a lab value or a biomarker to predict ultimate clinical results. These surrogates can be easier to collect, but the connection to the real outcomes patients care about (such as survival, symptom relief, or true cost impact) is not perfect. If the surrogate doesn’t track the true outcome well, decisions based on it can exaggerate or miss the real benefit or harm.

Outdated data add another layer of trouble. Data from the past may not reflect current practice, patient populations, costs, or technologies. Treatments evolve, prices change, and patient characteristics shift; using old data can lead to incorrect conclusions about effectiveness, safety, or value in today’s context.

Together, reliance on surrogate endpoints or outdated data can misrepresent true outcomes, which is why they’re considered problematic for accurate data interpretation. By contrast, focusing on direct, clinically meaningful endpoints and current, relevant data helps ensure conclusions reflect what actually matters to patients and to practice today.